Literature DB >> 18205320

Mass spectrometry-based metabolic profiling of rat urine associated with general toxicity induced by the multiglycoside of Tripterygium wilfordii Hook. f.

Minjun Chen1, Yan Ni, Hongquan Duan, Yunping Qiu, Congying Guo, Yang Jiao, Huijuan Shi, Mingming Su, Wei Jia.   

Abstract

We propose here a combined gas chromatography/mass spectrometry (GC/MS) and liquid chromatography/mass spectrometry (LC/MS) metabolic profiling strategy to elucidate the toxicity in rats induced by orally administered multiglycosides of Tripterygium wilfordii Hook. f. (GTW) in multiple organs including the kidney, liver, and testis. Overnight 12-h urine samples were collected from Sprague-Dawley male rats exposed to GTW (100 mg/kg/day, n = 6) and healthy controls ( n = 6) at predose and at the 1st, 3rd, 6th, 10th, and 14th day postdose for both GC/MS and LC/MS analyses. The integrated urinary MS data were analyzed via multivariate statistical techniques such as principal component analysis (PCA) and partial least squares-discriminant analysis (PLS-DA) to identify the differential metabolites and pertinent altered biological pathways in response to the herbal toxin. The liver, kidney, and testis were also assessed using conventional histopathological examinations at the end point of the experiment. This work indicates that GTW caused a time-dependent toxic effect at a high dose as revealed by the perturbed metabolic regulatory network involving disorders in energy metabolism, elevated amino acid and choline metabolism pathways, as well as altered structure of gut flora. This integrated MS-based metabolic profiling approach has been able to capture and probe the metabolic alterations associated with the onset and progression of multiorgan toxicity induced by GTW, thereby permitting a comprehensive understanding of systemic toxicity for phytochemicals and other types of xenobiotic agents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18205320     DOI: 10.1021/tx7002905

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  7 in total

Review 1.  Clinical trials of integrative medicine for rheumatoid arthritis: Issues and recommendations.

Authors:  Chi Zhang; Miao Jiang; Xiao-Juan He; Ai-Ping Lu
Journal:  Chin J Integr Med       Date:  2015-06-11       Impact factor: 1.978

Review 2.  Novel methodologies in analysis of small molecule biomarkers and living cells.

Authors:  Yinan Chen; Zhenggang Zhu; Yingyan Yu
Journal:  Tumour Biol       Date:  2014-08-14

Review 3.  Bioactive Ingredients in Chinese Herbal Medicines That Target Non-coding RNAs: Promising New Choices for Disease Treatment.

Authors:  Yan Dong; Hengwen Chen; Jialiang Gao; Yongmei Liu; Jun Li; Jie Wang
Journal:  Front Pharmacol       Date:  2019-05-21       Impact factor: 5.810

4.  Plasma metabolic profiling analysis of Cortex Periplocae-induced cardiotoxicity based on UPLC/Q-TOF-MS.

Authors:  Yubo Li; Chuanxin Liu; Jun Du; Xue Sheng; Yanjun Zhang
Journal:  RSC Adv       Date:  2018-01-29       Impact factor: 4.036

5.  Pharmacometabolomic approach to predict QT prolongation in guinea pigs.

Authors:  Jeonghyeon Park; Keumhan Noh; Hae Won Lee; Mi-sun Lim; Sook Jin Seong; Jeong Ju Seo; Eun-Jung Kim; Wonku Kang; Young-Ran Yoon
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

6.  Ginsenoside Rg1 protects against transient focal cerebral ischemic injury and suppresses its systemic metabolic changes in cerabral injury rats.

Authors:  Mingbao Lin; Wei Sun; Wan Gong; Yasi Ding; Yuanyan Zhuang; Qi Hou
Journal:  Acta Pharm Sin B       Date:  2015-04-08       Impact factor: 11.413

7.  Multi-TGDR, a multi-class regularization method, identifies the metabolic profiles of hepatocellular carcinoma and cirrhosis infected with hepatitis B or hepatitis C virus.

Authors:  Suyan Tian; Howard H Chang; Chi Wang; Jing Jiang; Xiaomei Wang; Junqi Niu
Journal:  BMC Bioinformatics       Date:  2014-04-04       Impact factor: 3.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.